Fracture risk and survival outcomes in metastatic castration-resistant prostate cancer patients sequentially treated with abiraterone acetate and RADIUM-223

Orazio Caffo, Viviana Frantellizzi, Marcello Tucci, Luca Galli, Fabio Monari, Sergio Baldari, Cristina Masini, Roberto Bortolus, Gaetano Facchini, Pierpaolo Alongi, Stefania Agostini, Clizia Zichi, Elisa Biasco, Stefano Fanti, Salvatore Pignata, Angelina Filice, Eugenio Borsatti, Sabrina Rossetti, Massimiliano Spada, Enrico CortesiGiuseppe De Vincentis

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Fracture risk and survival outcomes in metastatic castration-resistant prostate cancer patients sequentially treated with abiraterone acetate and RADIUM-223'. Together they form a unique fingerprint.

Medicine & Life Sciences